Left Ventricular Diastolic Dysfunction Increases the Risk of Medium-term Mortality in Patients with Cirrhotic Ascites

Sheng-Hao Li1, Lu Zhang1, Hong-Juan Li2

  • 1School of Public Health, School of Public Health, Dali University, no. 2, Hongsheng Road, Dali Town, Dali Bai Autonomous Prefecture, Dali City 671000, Yunnan Province, P.R. China.

Insights

Left ventricular diastolic dysfunction (LVDD) is an independent risk factor for 1-year mortality in patients with cirrhotic ascites. Early detection of LVDD can help predict prognosis, especially in patients without hepatic malignancy.

Area of Science:

  • Cardiology
  • Hepatology
  • Medical Prognostics

Background:

  • Cirrhotic ascites is a common complication of advanced liver disease.
  • Left ventricular diastolic dysfunction (LVDD) is increasingly recognized in patients with liver cirrhosis.
  • The prognostic implications of LVDD in cirrhotic ascites patients require further elucidation.

Purpose of the Study:

  • To investigate the association between left ventricular diastolic dysfunction (LVDD) and medium-term mortality in patients with cirrhotic ascites.
  • To identify LVDD as an independent risk factor for 1-year mortality in this population.
  • To compare the predictive value of LVDD with established prognostic scores.

Main Methods:

  • Retrospective study including 194 patients with cirrhotic ascites.
  • Echocardiography used to categorize patients into LVDD and non-LVDD groups.
  • Lasso, univariate, and multivariate Cox regression analyses for risk factor identification.
  • Kaplan-Meier curves and time-dependent ROC curves for survival analysis.

Main Results:

  • Left ventricular diastolic dysfunction (LVDD) was identified in 47.4% of patients.
  • LVDD was an independent predictor of 1-year mortality (Hazard Ratio = 2.109, P = 0.003).
  • LVDD demonstrated comparable predictive performance to CTP and MELD scores for 1-year mortality, particularly in patients without hepatic malignancy.

Conclusions:

  • Left ventricular diastolic dysfunction (LVDD) significantly increases the risk of 1-year mortality in patients with cirrhotic ascites.
  • LVDD serves as a valuable prognostic marker, especially in cirrhotic ascites patients without hepatic malignancy.
  • Routine echocardiographic assessment for LVDD may aid in risk stratification and management of cirrhotic ascites.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
693
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
392
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
420
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
449
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
452
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K